Transtek(SZ:300562) Sou Hu Cai Jing·2026-01-19 14:59Core Viewpoint - 乐心医疗 has received II class medical device registration for its blood glucose meter, which is expected to enhance its product competitiveness and expand its blood glucose business [1] Group 1: Company Performance - As of January 19, 2026, 乐心医疗's stock closed at 15.15 yuan, down 0.98% from the previous trading day, with a total market capitalization of 3.312 billion yuan [1] - The stock opened at 15.19 yuan, reached a high of 15.4 yuan, and a low of 14.95 yuan, with a trading volume of 185 million yuan and a turnover rate of 7.5% [1] Group 2: Product Development - The blood glucose meter, based on electrochemical principles, is designed for quantitative detection of whole blood glucose levels, suitable for home patients and healthcare professionals [1] - The model GBZ41-B features Bluetooth functionality, allowing data to be uploaded to a designated app [1] - The acquisition of the registration certificate is a significant advancement for the company's fundraising project, aiding in the implementation of its strategy [1] Group 3: Market Impact - The actual sales performance of the product will be influenced by market promotion efforts, and the future impact on the company's performance remains uncertain [1]